Research programme: cancer therapeutic companion diagnostics - Ventana Medical SystemsAlternative Names: Antibody-drug conjugate companion diagnostics - Ventana; Bayer ADC diagnostic test - Ventana; Bayer's biomarker targeted therapeutic diagnostic test - Ventana
Latest Information Update: 16 Jul 2016
At a glance
- Originator Ventana Medical Systems
- Class Monoclonal antibody diagnostics
- Mechanism of Action
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer